A systematic review and meta‐analysis of the prevalence and correlation of mild cognitive impairment in sarcopenia

Sarcopenia is a progressive skeletal muscle disorder involving the loss of muscle mass and function, associated with an increased risk of disability and frailty. Though its prevalence in dementia has been studied, its occurrence in mild cognitive impairment (MCI) has not been well established. As MC...

Full description

Saved in:
Bibliographic Details
Published inJournal of cachexia, sarcopenia and muscle Vol. 14; no. 1; pp. 45 - 56
Main Authors Yang, Ying, Xiao, Mengmeng, Leng, Lin, Jiang, Shixie, Feng, Lei, Pan, Gaofeng, Li, Zheng, Wang, Yan, Wang, Jiang, Wen, Yanting, Wu, Dan, Yang, Yongxue, Huang, Pan
Format Journal Article
LanguageEnglish
Published Germany John Wiley & Sons, Inc 01.02.2023
John Wiley and Sons Inc
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Sarcopenia is a progressive skeletal muscle disorder involving the loss of muscle mass and function, associated with an increased risk of disability and frailty. Though its prevalence in dementia has been studied, its occurrence in mild cognitive impairment (MCI) has not been well established. As MCI is often a prelude to dementia, our study aims to investigate the prevalence of MCI among individuals with sarcopenia and to also ascertain whether sarcopenia is independently associated with MCI. The Cochrane Library, PubMed, Ovid, Embase and Web of Science were systematically searched for articles on MCI and/or sarcopenia published from inception to 1 February 2022. We reviewed the available literature on the number of individuals with MCI and/or sarcopenia and calculated odds ratios (ORs) of sarcopenia in MCI and MCI in sarcopenia, respectively. Statistical analyses were performed using the meta package in Stata, Version 12.0. A total of 13 studies and 27 428 patients were included in our analysis. The pooled prevalence of MCI in participants with sarcopenia was 20.5% (95% confidence interval [CI]: 0.140–0.269) in a total sample of 2923 cases with a high level of heterogeneity (P < 0.001; I2 = 95.4%). The overall prevalence of sarcopenia with MCI was 9.1% (95% CI: 0.047–0.134, P < 0.001; I2 = 93.0%). For overall ORs, there were 23 364 subjects with a mean age of 73 years; the overall adjusted OR between MCI and sarcopenia was 1.46 (95% CI: 1.31–1.62). Slight heterogeneity in both adjusted ORs (P = 0.46; I2 = 0%) was noted across the studies. The prevalence of MCI is relatively high in patients with sarcopenia, and sarcopenia may be a risk factor for MCI.
AbstractList Sarcopenia is a progressive skeletal muscle disorder involving the loss of muscle mass and function, associated with an increased risk of disability and frailty. Though its prevalence in dementia has been studied, its occurrence in mild cognitive impairment (MCI) has not been well established. As MCI is often a prelude to dementia, our study aims to investigate the prevalence of MCI among individuals with sarcopenia and to also ascertain whether sarcopenia is independently associated with MCI. The Cochrane Library, PubMed, Ovid, Embase and Web of Science were systematically searched for articles on MCI and/or sarcopenia published from inception to 1 February 2022. We reviewed the available literature on the number of individuals with MCI and/or sarcopenia and calculated odds ratios (ORs) of sarcopenia in MCI and MCI in sarcopenia, respectively. Statistical analyses were performed using the meta package in Stata, Version 12.0. A total of 13 studies and 27 428 patients were included in our analysis. The pooled prevalence of MCI in participants with sarcopenia was 20.5% (95% confidence interval [CI]: 0.140-0.269) in a total sample of 2923 cases with a high level of heterogeneity (P < 0.001; I  = 95.4%). The overall prevalence of sarcopenia with MCI was 9.1% (95% CI: 0.047-0.134, P < 0.001; I  = 93.0%). For overall ORs, there were 23 364 subjects with a mean age of 73 years; the overall adjusted OR between MCI and sarcopenia was 1.46 (95% CI: 1.31-1.62). Slight heterogeneity in both adjusted ORs (P = 0.46; I  = 0%) was noted across the studies. The prevalence of MCI is relatively high in patients with sarcopenia, and sarcopenia may be a risk factor for MCI.
Sarcopenia is a progressive skeletal muscle disorder involving the loss of muscle mass and function, associated with an increased risk of disability and frailty. Though its prevalence in dementia has been studied, its occurrence in mild cognitive impairment (MCI) has not been well established. As MCI is often a prelude to dementia, our study aims to investigate the prevalence of MCI among individuals with sarcopenia and to also ascertain whether sarcopenia is independently associated with MCI. The Cochrane Library, PubMed, Ovid, Embase and Web of Science were systematically searched for articles on MCI and/or sarcopenia published from inception to 1 February 2022. We reviewed the available literature on the number of individuals with MCI and/or sarcopenia and calculated odds ratios (ORs) of sarcopenia in MCI and MCI in sarcopenia, respectively. Statistical analyses were performed using the meta package in Stata, Version 12.0. A total of 13 studies and 27 428 patients were included in our analysis. The pooled prevalence of MCI in participants with sarcopenia was 20.5% (95% confidence interval [CI]: 0.140–0.269) in a total sample of 2923 cases with a high level of heterogeneity ( P  < 0.001; I 2  = 95.4%). The overall prevalence of sarcopenia with MCI was 9.1% (95% CI: 0.047–0.134, P  < 0.001; I 2  = 93.0%). For overall ORs, there were 23 364 subjects with a mean age of 73 years; the overall adjusted OR between MCI and sarcopenia was 1.46 (95% CI: 1.31–1.62). Slight heterogeneity in both adjusted ORs ( P  = 0.46; I 2  = 0%) was noted across the studies. The prevalence of MCI is relatively high in patients with sarcopenia, and sarcopenia may be a risk factor for MCI.
Sarcopenia is a progressive skeletal muscle disorder involving the loss of muscle mass and function, associated with an increased risk of disability and frailty. Though its prevalence in dementia has been studied, its occurrence in mild cognitive impairment (MCI) has not been well established. As MCI is often a prelude to dementia, our study aims to investigate the prevalence of MCI among individuals with sarcopenia and to also ascertain whether sarcopenia is independently associated with MCI. The Cochrane Library, PubMed, Ovid, Embase and Web of Science were systematically searched for articles on MCI and/or sarcopenia published from inception to 1 February 2022. We reviewed the available literature on the number of individuals with MCI and/or sarcopenia and calculated odds ratios (ORs) of sarcopenia in MCI and MCI in sarcopenia, respectively. Statistical analyses were performed using the meta package in Stata, Version 12.0. A total of 13 studies and 27 428 patients were included in our analysis. The pooled prevalence of MCI in participants with sarcopenia was 20.5% (95% confidence interval [CI]: 0.140–0.269) in a total sample of 2923 cases with a high level of heterogeneity (P < 0.001; I2 = 95.4%). The overall prevalence of sarcopenia with MCI was 9.1% (95% CI: 0.047–0.134, P < 0.001; I2 = 93.0%). For overall ORs, there were 23 364 subjects with a mean age of 73 years; the overall adjusted OR between MCI and sarcopenia was 1.46 (95% CI: 1.31–1.62). Slight heterogeneity in both adjusted ORs (P = 0.46; I2 = 0%) was noted across the studies. The prevalence of MCI is relatively high in patients with sarcopenia, and sarcopenia may be a risk factor for MCI.
Sarcopenia is a progressive skeletal muscle disorder involving the loss of muscle mass and function, associated with an increased risk of disability and frailty. Though its prevalence in dementia has been studied, its occurrence in mild cognitive impairment (MCI) has not been well established. As MCI is often a prelude to dementia, our study aims to investigate the prevalence of MCI among individuals with sarcopenia and to also ascertain whether sarcopenia is independently associated with MCI. The Cochrane Library, PubMed, Ovid, Embase and Web of Science were systematically searched for articles on MCI and/or sarcopenia published from inception to 1 February 2022. We reviewed the available literature on the number of individuals with MCI and/or sarcopenia and calculated odds ratios (ORs) of sarcopenia in MCI and MCI in sarcopenia, respectively. Statistical analyses were performed using the meta package in Stata, Version 12.0. A total of 13 studies and 27 428 patients were included in our analysis. The pooled prevalence of MCI in participants with sarcopenia was 20.5% (95% confidence interval [CI]: 0.140-0.269) in a total sample of 2923 cases with a high level of heterogeneity (P < 0.001; I2 = 95.4%). The overall prevalence of sarcopenia with MCI was 9.1% (95% CI: 0.047-0.134, P < 0.001; I2 = 93.0%). For overall ORs, there were 23 364 subjects with a mean age of 73 years; the overall adjusted OR between MCI and sarcopenia was 1.46 (95% CI: 1.31-1.62). Slight heterogeneity in both adjusted ORs (P = 0.46; I2 = 0%) was noted across the studies. The prevalence of MCI is relatively high in patients with sarcopenia, and sarcopenia may be a risk factor for MCI.Sarcopenia is a progressive skeletal muscle disorder involving the loss of muscle mass and function, associated with an increased risk of disability and frailty. Though its prevalence in dementia has been studied, its occurrence in mild cognitive impairment (MCI) has not been well established. As MCI is often a prelude to dementia, our study aims to investigate the prevalence of MCI among individuals with sarcopenia and to also ascertain whether sarcopenia is independently associated with MCI. The Cochrane Library, PubMed, Ovid, Embase and Web of Science were systematically searched for articles on MCI and/or sarcopenia published from inception to 1 February 2022. We reviewed the available literature on the number of individuals with MCI and/or sarcopenia and calculated odds ratios (ORs) of sarcopenia in MCI and MCI in sarcopenia, respectively. Statistical analyses were performed using the meta package in Stata, Version 12.0. A total of 13 studies and 27 428 patients were included in our analysis. The pooled prevalence of MCI in participants with sarcopenia was 20.5% (95% confidence interval [CI]: 0.140-0.269) in a total sample of 2923 cases with a high level of heterogeneity (P < 0.001; I2 = 95.4%). The overall prevalence of sarcopenia with MCI was 9.1% (95% CI: 0.047-0.134, P < 0.001; I2 = 93.0%). For overall ORs, there were 23 364 subjects with a mean age of 73 years; the overall adjusted OR between MCI and sarcopenia was 1.46 (95% CI: 1.31-1.62). Slight heterogeneity in both adjusted ORs (P = 0.46; I2 = 0%) was noted across the studies. The prevalence of MCI is relatively high in patients with sarcopenia, and sarcopenia may be a risk factor for MCI.
Abstract Sarcopenia is a progressive skeletal muscle disorder involving the loss of muscle mass and function, associated with an increased risk of disability and frailty. Though its prevalence in dementia has been studied, its occurrence in mild cognitive impairment (MCI) has not been well established. As MCI is often a prelude to dementia, our study aims to investigate the prevalence of MCI among individuals with sarcopenia and to also ascertain whether sarcopenia is independently associated with MCI. The Cochrane Library, PubMed, Ovid, Embase and Web of Science were systematically searched for articles on MCI and/or sarcopenia published from inception to 1 February 2022. We reviewed the available literature on the number of individuals with MCI and/or sarcopenia and calculated odds ratios (ORs) of sarcopenia in MCI and MCI in sarcopenia, respectively. Statistical analyses were performed using the meta package in Stata, Version 12.0. A total of 13 studies and 27 428 patients were included in our analysis. The pooled prevalence of MCI in participants with sarcopenia was 20.5% (95% confidence interval [CI]: 0.140–0.269) in a total sample of 2923 cases with a high level of heterogeneity (P < 0.001; I2 = 95.4%). The overall prevalence of sarcopenia with MCI was 9.1% (95% CI: 0.047–0.134, P < 0.001; I2 = 93.0%). For overall ORs, there were 23 364 subjects with a mean age of 73 years; the overall adjusted OR between MCI and sarcopenia was 1.46 (95% CI: 1.31–1.62). Slight heterogeneity in both adjusted ORs (P = 0.46; I2 = 0%) was noted across the studies. The prevalence of MCI is relatively high in patients with sarcopenia, and sarcopenia may be a risk factor for MCI.
Sarcopenia is a progressive skeletal muscle disorder involving the loss of muscle mass and function, associated with an increased risk of disability and frailty. Though its prevalence in dementia has been studied, its occurrence in mild cognitive impairment (MCI) has not been well established. As MCI is often a prelude to dementia, our study aims to investigate the prevalence of MCI among individuals with sarcopenia and to also ascertain whether sarcopenia is independently associated with MCI. The Cochrane Library, PubMed, Ovid, Embase and Web of Science were systematically searched for articles on MCI and/or sarcopenia published from inception to 1 February 2022. We reviewed the available literature on the number of individuals with MCI and/or sarcopenia and calculated odds ratios (ORs) of sarcopenia in MCI and MCI in sarcopenia, respectively. Statistical analyses were performed using the meta package in Stata, Version 12.0. A total of 13 studies and 27 428 patients were included in our analysis. The pooled prevalence of MCI in participants with sarcopenia was 20.5% (95% confidence interval [CI]: 0.140–0.269) in a total sample of 2923 cases with a high level of heterogeneity (P < 0.001; I2 = 95.4%). The overall prevalence of sarcopenia with MCI was 9.1% (95% CI: 0.047–0.134, P < 0.001; I2 = 93.0%). For overall ORs, there were 23 364 subjects with a mean age of 73 years; the overall adjusted OR between MCI and sarcopenia was 1.46 (95% CI: 1.31–1.62). Slight heterogeneity in both adjusted ORs (P = 0.46; I2 = 0%) was noted across the studies. The prevalence of MCI is relatively high in patients with sarcopenia, and sarcopenia may be a risk factor for MCI.
Author Li, Zheng
Yang, Ying
Wen, Yanting
Jiang, Shixie
Yang, Yongxue
Wang, Yan
Huang, Pan
Xiao, Mengmeng
Pan, Gaofeng
Wang, Jiang
Feng, Lei
Leng, Lin
Wu, Dan
AuthorAffiliation 3 College of Nursing Wenzhou Medical University Wenzhou China
6 Department of Psychiatry and Behavioral Sciences Stanford University School of Medicine Palo Alto CA USA
7 Department of Ultrasound Medicine Chengdu Fifth People's Hospital Chengdu China
4 Department of Medicine Jinggangshan University Ji'an China
2 Chongqing University of Posts and Telecommunications Chongqing China
5 Department of Nephrology Chengdu Fifth People's Hospital Chengdu China
1 Department of Neurology Geriatric Diseases Institute of Chengdu/Cancer Prevention and Treatment Institute of Chengdu, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine) Chengdu China
AuthorAffiliation_xml – name: 7 Department of Ultrasound Medicine Chengdu Fifth People's Hospital Chengdu China
– name: 5 Department of Nephrology Chengdu Fifth People's Hospital Chengdu China
– name: 1 Department of Neurology Geriatric Diseases Institute of Chengdu/Cancer Prevention and Treatment Institute of Chengdu, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine) Chengdu China
– name: 6 Department of Psychiatry and Behavioral Sciences Stanford University School of Medicine Palo Alto CA USA
– name: 2 Chongqing University of Posts and Telecommunications Chongqing China
– name: 3 College of Nursing Wenzhou Medical University Wenzhou China
– name: 4 Department of Medicine Jinggangshan University Ji'an China
Author_xml – sequence: 1
  givenname: Ying
  surname: Yang
  fullname: Yang, Ying
  organization: Chongqing University of Posts and Telecommunications
– sequence: 2
  givenname: Mengmeng
  surname: Xiao
  fullname: Xiao, Mengmeng
  organization: Jinggangshan University
– sequence: 3
  givenname: Lin
  surname: Leng
  fullname: Leng, Lin
  organization: Chengdu Fifth People's Hospital
– sequence: 4
  givenname: Shixie
  surname: Jiang
  fullname: Jiang, Shixie
  organization: Stanford University School of Medicine
– sequence: 5
  givenname: Lei
  surname: Feng
  fullname: Feng, Lei
  organization: Geriatric Diseases Institute of Chengdu/Cancer Prevention and Treatment Institute of Chengdu, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine)
– sequence: 6
  givenname: Gaofeng
  surname: Pan
  fullname: Pan, Gaofeng
  organization: Geriatric Diseases Institute of Chengdu/Cancer Prevention and Treatment Institute of Chengdu, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine)
– sequence: 7
  givenname: Zheng
  surname: Li
  fullname: Li, Zheng
  organization: Geriatric Diseases Institute of Chengdu/Cancer Prevention and Treatment Institute of Chengdu, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine)
– sequence: 8
  givenname: Yan
  surname: Wang
  fullname: Wang, Yan
  organization: Geriatric Diseases Institute of Chengdu/Cancer Prevention and Treatment Institute of Chengdu, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine)
– sequence: 9
  givenname: Jiang
  surname: Wang
  fullname: Wang, Jiang
  organization: Jinggangshan University
– sequence: 10
  givenname: Yanting
  surname: Wen
  fullname: Wen, Yanting
  organization: Chengdu Fifth People's Hospital
– sequence: 11
  givenname: Dan
  surname: Wu
  fullname: Wu, Dan
  organization: Chongqing University of Posts and Telecommunications
– sequence: 12
  givenname: Yongxue
  surname: Yang
  fullname: Yang, Yongxue
  email: 372574497@qq.com
  organization: Geriatric Diseases Institute of Chengdu/Cancer Prevention and Treatment Institute of Chengdu, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine)
– sequence: 13
  givenname: Pan
  surname: Huang
  fullname: Huang, Pan
  email: hpzyqzjh@163.com
  organization: Wenzhou Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36529141$$D View this record in MEDLINE/PubMed
BookMark eNp9kt9qFDEUhwep2Fp74wPIgDdF2JpkkpnkRiiLfyoVL9TrkMmcbLNkkjGZ3bJ3PoLP6JOY2VmLLWJuEpLvfOTHOU-LIx88FMVzjC4wQuT1Wqf-AleYVo-KE4IFWtQIiaPDmQmBj4uzlNYoL1rjmqEnxXFVMyIwxSfFeFmmXRqhV6PVZYSthdtS-a7sYVS_fvxUXrldsqkMphxvoBwyohx4DXtKhxjB5drgJ6K3brpbeTvaLZS2H5SNPfixtL5MKuowgLfqWfHYKJfg7LCfFt_evf26_LC4_vz-anl5vdA14tUCKsE7xauK604o4KLFDCjpGLDOKEFIDlpXvG6NblrR0LpGkMN33FCMqNLVaXE1e7ug1nKItldxJ4Oycn8R4kqqmHM7kF2NTUO0oS0iNMtbxgBXhiBQxmjSZdeb2TVs2h46nUNF5e5J7794eyNXYSsFF1hQngXnB0EM3zeQRtnbpME55SFskiQNYxwhxllGXz5A12ETcycmqsG0aRo-CV_8_aO7r_xpbgZezYCOIaUI5g7BSE7DI6fhkfvhyTB6AGs77hub01j37xI8l9xaB7v_yOXH5ZdPc81vwqHZiA
CitedBy_id crossref_primary_10_1016_j_gerinurse_2024_12_019
crossref_primary_10_1016_j_maturitas_2025_108193
crossref_primary_10_1007_s40520_025_02980_2
crossref_primary_10_3389_fpubh_2025_1547425
crossref_primary_10_1007_s00702_024_02865_0
crossref_primary_10_3390_nu17020248
crossref_primary_10_1186_s12877_024_05035_9
crossref_primary_10_1111_ijn_13306
crossref_primary_10_3390_metabo15030159
crossref_primary_10_1016_j_heliyon_2023_e23181
crossref_primary_10_1177_20552076241283247
crossref_primary_10_7189_jogh_14_04163
crossref_primary_10_1016_j_ijnss_2023_11_002
crossref_primary_10_5582_bst_2023_01211
crossref_primary_10_3389_fnins_2024_1352129
crossref_primary_10_1016_j_heliyon_2024_e33832
crossref_primary_10_1016_j_jnha_2024_100268
crossref_primary_10_1007_s40520_024_02781_z
crossref_primary_10_1002_jcsm_13485
crossref_primary_10_2147_CIA_S425271
crossref_primary_10_7475_kjan_2023_35_4_303
crossref_primary_10_1002_ajim_23685
crossref_primary_10_1038_s41598_024_69925_z
crossref_primary_10_1590_1980_265x_tce_2023_0149pt
crossref_primary_10_1111_acel_14263
crossref_primary_10_1016_j_archger_2023_105038
crossref_primary_10_1016_j_nut_2024_112568
crossref_primary_10_1097_JCMA_0000000000001164
crossref_primary_10_3389_fneur_2024_1496871
crossref_primary_10_1016_j_exger_2024_112487
crossref_primary_10_1186_s12889_024_18848_5
crossref_primary_10_3389_fmed_2023_1160426
crossref_primary_10_1016_j_mad_2024_111936
crossref_primary_10_1002_alz_14503
crossref_primary_10_1007_s12603_023_1973_2
crossref_primary_10_1016_j_archger_2023_105160
crossref_primary_10_1016_j_bbrc_2024_150606
crossref_primary_10_1186_s12889_024_20197_2
crossref_primary_10_1007_s41999_023_00921_8
crossref_primary_10_1016_j_jtcms_2025_03_010
crossref_primary_10_1093_braincomms_fcad347
crossref_primary_10_1590_1980_265x_tce_2023_0149en
crossref_primary_10_7189_jogh_13_04182
crossref_primary_10_1007_s12603_023_2006_x
crossref_primary_10_1016_j_regg_2024_101499
Cites_doi 10.3233/JAD-210321
10.1002/jcsm.12908
10.1186/s12877-021-02190-1
10.1093/ageing/afy169
10.1159/000513247
10.1016/j.jamda.2017.06.012
10.1016/j.clnu.2018.09.026
10.1017/S0714980809090126
10.1016/j.exger.2019.110798
10.1007/s11920-016-0721-2
10.1016/j.arr.2017.09.003
10.1002/hep.30702
10.3945/an.116.013474
10.1016/S0140-6736(19)31138-9
10.1016/j.freeradbiomed.2018.08.035
10.1007/s11136-017-1651-0
10.1007/s12603-019-1188-8
10.1007/s00415-019-09506-7
10.1016/j.chest.2019.04.115
10.3390/jcm9072133
10.1016/S1474-4422(06)70355-6
10.1016/j.arr.2016.09.008
10.1186/s12877-020-1468-5
10.1016/j.clnu.2013.04.002
10.1186/s12877-015-0169-y
10.1016/j.arr.2021.101395
10.1111/jgs.15642
10.1016/j.jamda.2013.05.009
10.1016/j.smrv.2021.101488
10.1002/jcsm.12787
10.1007/978-3-319-57379-3_19
10.1186/s40200-017-0302-x
10.1016/j.neubiorev.2013.04.005
10.1002/gps.5016
10.1007/s41999-019-00233-w
10.1016/j.jad.2021.02.067
10.1111/acps.12008
10.1111/jgs.17206
10.22540/JFSF-05-017
10.1002/jcsm.12899
10.1007/s40520-021-01883-2
10.1016/j.jaad.2017.05.019
10.1016/j.jalz.2016.07.151
10.1111/jgs.17520
10.1016/j.exger.2019.110801
10.1016/j.biopha.2020.110721
10.1186/s12929-019-0524-y
10.31887/DCNS.2009.11.2/cqiu
10.1016/j.jbspin.2018.08.001
10.2174/1567205013666160211124828
ContentType Journal Article
Copyright 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.
2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.
– notice: 2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1002/jcsm.13143
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE


MEDLINE - Academic

CrossRef
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Prevalence and correlation of MCI in sarcopenia
EISSN 2190-6009
EndPage 56
ExternalDocumentID oai_doaj_org_article_d61f72cf4b024fa9b55e13f20eaffc2d
PMC9891948
36529141
10_1002_jcsm_13143
JCSM13143
Genre reviewArticle
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Journal Article
GeographicLocations United States--US
China
Japan
Mexico
South Africa
Ghana
Russia
India
GeographicLocations_xml – name: South Africa
– name: Ghana
– name: India
– name: Japan
– name: Mexico
– name: China
– name: Russia
– name: United States--US
GrantInformation_xml – fundername: Service Efficiency Analysis of the Health Management of Geriatric Mental Disease on Computer Diagnosis System
– fundername: Chengdu Science and Technology Bureau
  funderid: 2021‐YF09‐00046‐SN
– fundername: Chengdu Fifth People's Hospital
  funderid: GSPZX2022‐03
– fundername: Chengdu Science and Technology Bureau
  grantid: 2021-YF09-00046-SN
– fundername: Chengdu Fifth People's Hospital
  grantid: GSPZX2022-03
– fundername: ;
  grantid: 2021‐YF09‐00046‐SN
– fundername: Chengdu Fifth People's Hospital
  grantid: GSPZX2022‐03
GroupedDBID ---
0R~
1OC
24P
2VQ
4.4
40G
53G
5VS
7X7
8FI
8FJ
AAHHS
AAKDD
AAZKR
ABUWG
ACCFJ
ACCMX
ACXQS
ADBBV
ADINQ
ADKYN
ADPDF
ADRAZ
ADZMN
ADZOD
AEEZP
AENEX
AEQDE
AFKRA
AHBYD
AHSBF
AIWBW
AJBDE
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMKLP
AOIJS
AVUZU
AZFZN
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
DIK
EBS
EJD
EMOBN
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
INH
ITC
KQ8
M48
M~E
O9-
OK1
OVD
OVEED
PIMPY
PQQKQ
PROAC
RPM
RSV
SMD
SOJ
U2A
UKHRP
WIN
ZOVNA
AAFWJ
AAYXX
AFPKN
CITATION
PHGZM
PHGZT
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c6083-e398da8338cd9ae89b15e42d5e5dfa9220096386bfc7b974660e600d8f4104ac3
IEDL.DBID M48
ISSN 2190-5991
2190-6009
IngestDate Wed Aug 27 01:33:01 EDT 2025
Thu Aug 21 18:38:07 EDT 2025
Fri Jul 11 12:09:41 EDT 2025
Sat Jul 26 02:18:49 EDT 2025
Mon Jul 21 05:46:44 EDT 2025
Tue Jul 01 02:51:34 EDT 2025
Thu Apr 24 22:57:20 EDT 2025
Wed Jan 22 16:17:35 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords mild cognitive impairment (MCI)
risk factor
elderly
sarcopenia
Language English
License Attribution-NonCommercial-NoDerivs
2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c6083-e398da8338cd9ae89b15e42d5e5dfa9220096386bfc7b974660e600d8f4104ac3
Notes Funding information
This study was supported by grants from the Chengdu Science and Technology Bureau, Key Research and Development Support Program (No. 2021‐YF09‐00046‐SN, empirical research); Scientific Research Project of Chengdu Fifth People's Hospital (No. GSPZX2022‐03); and Service Efficiency Analysis of the Health Management of Geriatric Mental Disease on Computer Diagnosis System.
Ying Yang, Mengmeng Xiao and Lin Leng are co‐first authors.
ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Feature-1
ObjectType-Review-4
content type line 23
ObjectType-Undefined-3
Funding information This study was supported by grants from the Chengdu Science and Technology Bureau, Key Research and Development Support Program (No. 2021‐YF09‐00046‐SN, empirical research); Scientific Research Project of Chengdu Fifth People's Hospital (No. GSPZX2022‐03); and Service Efficiency Analysis of the Health Management of Geriatric Mental Disease on Computer Diagnosis System.
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1002/jcsm.13143
PMID 36529141
PQID 2771477788
PQPubID 4370305
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_d61f72cf4b024fa9b55e13f20eaffc2d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9891948
proquest_miscellaneous_2755800585
proquest_journals_2771477788
pubmed_primary_36529141
crossref_primary_10_1002_jcsm_13143
crossref_citationtrail_10_1002_jcsm_13143
wiley_primary_10_1002_jcsm_13143_JCSM13143
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2023
PublicationDateYYYYMMDD 2023-02-01
PublicationDate_xml – month: 02
  year: 2023
  text: February 2023
PublicationDecade 2020
PublicationPlace Germany
PublicationPlace_xml – name: Germany
– name: Heidelberg
– name: Hoboken
PublicationTitle Journal of cachexia, sarcopenia and muscle
PublicationTitleAlternate J Cachexia Sarcopenia Muscle
PublicationYear 2023
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
– name: Wiley
References 2021; 69
2017; 40
2017; 8
2021; 21
2021; 67
2020; 20
2022; 70
2019; 10
2013; 127
2021; 286
2021; 70
2018; 47
2009; 11
2020; 5
2013; 14
2021; 33
2020; 130
2020; 131
2017; 77
2019; 67
2019; 23
2017; 35
2019; 26
2020; 9
2019; 393
2021; 82
2019; 156
2015; 15
2019; 70
2017; 26
2021; 268
2019; 34
2019; 38
2006; 5
2016; 18
2016; 13
2009; 28
2021; 58
2013; 37
2021; 12
2013; 33
2019; 86
2017; 16
2019; 48
2017; 13
2019
2022; 13
2017; 18
2017; 987
2019; 132
e_1_2_8_24_1
e_1_2_8_47_1
e_1_2_8_26_1
e_1_2_8_49_1
e_1_2_8_5_1
e_1_2_8_7_1
e_1_2_8_9_1
e_1_2_8_20_1
e_1_2_8_43_1
e_1_2_8_22_1
e_1_2_8_45_1
e_1_2_8_41_1
e_1_2_8_17_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_15_1
e_1_2_8_38_1
Prince M (e_1_2_8_3_1) 2019
e_1_2_8_32_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_53_1
e_1_2_8_51_1
e_1_2_8_30_1
e_1_2_8_29_1
Lee I (e_1_2_8_28_1) 2018; 47
e_1_2_8_25_1
e_1_2_8_46_1
e_1_2_8_27_1
e_1_2_8_48_1
e_1_2_8_2_1
e_1_2_8_4_1
e_1_2_8_6_1
e_1_2_8_8_1
e_1_2_8_21_1
e_1_2_8_42_1
e_1_2_8_23_1
e_1_2_8_44_1
e_1_2_8_40_1
e_1_2_8_18_1
e_1_2_8_39_1
e_1_2_8_14_1
e_1_2_8_35_1
e_1_2_8_16_1
e_1_2_8_37_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_54_1
e_1_2_8_52_1
e_1_2_8_50_1
References_xml – volume: 48
  start-page: 16
  year: 2019
  end-page: 31
  article-title: Sarcopenia: revised European consensus on definition and diagnosis
  publication-title: Age Ageing
– volume: 67
  start-page: 386
  year: 2021
  end-page: 396
  article-title: The comparison of sarcopenia diagnostic criteria using AWGS 2019 with the other five criteria in West China
  publication-title: Gerontology
– volume: 5
  start-page: 17
  year: 2020
  end-page: 23
  article-title: Content of exercise programmes targeting older people with sarcopenia or frailty—findings from a UK survey
  publication-title: J Frailty Sarcopenia Falls
– volume: 28
  start-page: 147
  year: 2009
  end-page: 156
  article-title: Personality and psychological health in persons with mild cognitive impairment
  publication-title: Can J Aging
– volume: 14
  start-page: 877
  year: 2013
  end-page: 882
  article-title: Proinflammatory cytokines, aging, and age‐related diseases
  publication-title: J Am Med Dir Assoc
– volume: 18
  start-page: 85
  year: 2016
  article-title: Cognitive reserve and the prevention of dementia: the role of physical and cognitive activities
  publication-title: Curr Psychiatry Rep
– volume: 34
  start-page: 233
  year: 2019
  end-page: 242
  article-title: Cognitive tests for the detection of mild cognitive impairment (MCI), the prodromal stage of dementia: meta‐analysis of diagnostic accuracy studies
  publication-title: Int J Geriatr Psychiatry
– volume: 21
  start-page: 292
  year: 2021
  article-title: Associations of sarcopenia and its defining components with cognitive function in community‐dwelling oldest old
  publication-title: BMC Geriatr
– volume: 33
  start-page: 3215
  year: 2021
  end-page: 3222
  article-title: Nutritional status mediates the relationship between sarcopenia and cognitive impairment: findings from the WCHAT study
  publication-title: Aging Clin Exp Res
– volume: 38
  start-page: 1489
  year: 2019
  end-page: 1495
  article-title: Financial impact of sarcopenia or low muscle mass—a short review
  publication-title: Clin Nutr (Edinburgh, Scotland)
– volume: 5
  start-page: 228
  year: 2006
  end-page: 234
  article-title: Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow‐up study
  publication-title: Lancet Neurol
– volume: 18
  start-page: 809.e9
  year: 2017
  end-page: 809.e13
  article-title: Association between sarcopenia and mild cognitive impairment using the Japanese version of the SARC‐F in elderly patients with diabetes
  publication-title: J Am Med Dir Assoc
– volume: 33
  start-page: 64
  year: 2013
  end-page: 68
  article-title: Prevalence of and factors associated with sarcopenia in elderly patients with end‐stage renal disease
  publication-title: Clin Nutr (Edinburgh, Scotland)
– volume: 77
  start-page: 425
  year: 2017
  end-page: 440 e422
  article-title: Psoriasis and suicidality: a systematic review and meta‐analysis
  publication-title: J Am Acad Dermatol
– volume: 23
  start-page: 525
  year: 2019
  end-page: 531
  article-title: Sarcopenia is associated with cognitive impairment in older adults: a systematic review and meta‐analysis
  publication-title: J Nutr Health Aging
– volume: 40
  start-page: 75
  year: 2017
  end-page: 83
  article-title: Positive effects of combined cognitive and physical exercise training on cognitive function in older adults with mild cognitive impairment or dementia: a meta‐analysis
  publication-title: Ageing Res Rev
– volume: 130
  year: 2020
  article-title: Comparison of revised EWGSOP criteria and four other diagnostic criteria of sarcopenia in Chinese community‐dwelling elderly residents
  publication-title: Exp Gerontol
– volume: 286
  start-page: 71
  year: 2021
  end-page: 77
  article-title: Relationships between sarcopenia, depressive symptoms, and mild cognitive impairment in Chinese community‐dwelling older adults
  publication-title: J Affect Disord
– volume: 9
  year: 2020
  article-title: Walking speed is the sole determinant criterion of sarcopenia of mild cognitive impairment in Japanese elderly patients with type 2 diabetes mellitus
  publication-title: J Clin Med
– volume: 393
  start-page: 2636
  year: 2019
  end-page: 2646
  article-title: Sarcopenia
  publication-title: Lancet
– volume: 12
  start-page: 1848
  year: 2021
  end-page: 1859
  article-title: Longitudinal association of sarcopenia and mild cognitive impairment among older Mexican adults
  publication-title: J Cachexia Sarcopenia Muscle
– volume: 13
  start-page: 128
  year: 2022
  end-page: 144
  article-title: Prevalence of depression in patients with sarcopenia and correlation between the two diseases: systematic review and meta‐analysis
  publication-title: J Cachexia Sarcopenia Muscle
– year: 2019
– volume: 82
  start-page: 1745
  year: 2021
  end-page: 1754
  article-title: Sarcopenia and mild cognitive impairment in older adults from six low‐ and middle‐income countries
  publication-title: J Alzheimers Dis
– volume: 131
  year: 2020
  article-title: New understanding of the pathogenesis and treatment of stroke‐related sarcopenia
  publication-title: Biomed Pharmacother
– volume: 10
  start-page: 853
  year: 2019
  end-page: 862
  article-title: Sarcopenia and health‐related outcomes: an umbrella review of observational studies
  publication-title: Eur Geriatr Med
– volume: 156
  start-page: 101
  year: 2019
  end-page: 111
  article-title: Prognostic value of sarcopenia in lung cancer: a systematic review and meta‐analysis
  publication-title: chest
– volume: 70
  year: 2021
  article-title: Cross‐sectional and longitudinal associations between adherence to Mediterranean diet with physical performance and cognitive function in older adults: a systematic review and meta‐analysis
  publication-title: Ageing Res Rev
– volume: 13
  start-page: 718
  year: 2016
  end-page: 726
  article-title: Prevalence and associated factors of sarcopenia in elderly subjects with amnestic mild cognitive impairment or Alzheimer disease
  publication-title: Curr Alzheimer Res
– volume: 26
  start-page: 33
  year: 2019
  article-title: Alzheimer's disease: risk factors and potentially protective measures
  publication-title: J Biomed Sci
– volume: 11
  start-page: 111
  year: 2009
  end-page: 128
  article-title: Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention
  publication-title: Dialogues Clin Neurosci
– volume: 132
  start-page: 42
  year: 2019
  end-page: 49
  article-title: Sarcopenia, frailty and their prevention by exercise
  publication-title: Free Radic Biol Med
– volume: 47
  start-page: 327
  year: 2018
  end-page: 334
  article-title: Sarcopenia is associated with cognitive impairment and depression in elderly Korean women
  publication-title: Iran J Public Health
– volume: 70
  start-page: 1119
  year: 2019
  end-page: 1133
  article-title: Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta‐analysis
  publication-title: Hepatology
– volume: 987
  start-page: 213
  year: 2017
  end-page: 218
  article-title: Sarcopenia and its impact on quality of life
  publication-title: Adv Exp Med Biol
– volume: 20
  start-page: 63
  year: 2020
  article-title: Prevalence of sarcopenia in multi ethnics adults and the association with cognitive impairment: findings from West‐China health and aging trend study
  publication-title: BMC Geriatr
– volume: 12
  start-page: 2259
  year: 2021
  end-page: 2261
  article-title: Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021
  publication-title: J Cachexia Sarcopenia Muscle
– volume: 15
  start-page: 172
  year: 2015
  article-title: The relationships between body composition characteristics and cognitive functioning in a population‐based sample of older British men
  publication-title: BMC Geriatr
– volume: 26
  start-page: 2899
  year: 2017
  end-page: 2907
  article-title: The quality of life of older people aging in place: a literature review
  publication-title: Qual Life Res
– volume: 13
  start-page: 399
  year: 2017
  end-page: 405
  article-title: Progression from normal cognition to mild cognitive impairment in a diverse clinic‐based and community‐based elderly cohort
  publication-title: Alzheimers Dement
– volume: 35
  start-page: 200
  year: 2017
  end-page: 221
  article-title: Sarcopenic obesity or obese sarcopenia: a cross talk between age‐associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis
  publication-title: Ageing Res Rev
– volume: 67
  start-page: 232
  year: 2019
  end-page: 238
  article-title: Mild cognitive impairment that does not progress to dementia: a population‐based study
  publication-title: J Am Geriatr Soc
– volume: 58
  year: 2021
  article-title: Polysomnographic nighttime features of narcolepsy: a systematic review and meta‐analysis
  publication-title: Sleep Med Rev
– volume: 69
  start-page: 1826
  year: 2021
  end-page: 1835
  article-title: Sarcopenia is associated with incident Alzheimer's dementia, mild cognitive impairment, and cognitive decline
  publication-title: J Am Geriatr Soc
– volume: 70
  start-page: 481
  year: 2022
  end-page: 489
  article-title: Life expectancy with and without dementia in persons with mild cognitive impairment in the community
  publication-title: J Am Geriatr Soc
– volume: 37
  start-page: 2243
  year: 2013
  end-page: 2257
  article-title: Beneficial effects of physical exercise on neuroplasticity and cognition
  publication-title: Neurosci Biobehav Rev
– volume: 16
  start-page: 21
  year: 2017
  article-title: Prevalence of sarcopenia in the world: a systematic review and meta‐analysis of general population studies
  publication-title: J Diabetes Metab Disord
– volume: 127
  start-page: 394
  year: 2013
  end-page: 402
  article-title: Prevalence and characteristics of depression in mild cognitive impairment: the Sydney Memory and Ageing Study
  publication-title: Acta Psychiatr Scand
– volume: 86
  start-page: 309
  year: 2019
  end-page: 314
  article-title: Sarcopenia
  publication-title: Joint Bone Spine
– volume: 131
  year: 2020
  article-title: Prevalence of sarcopenia as a comorbid disease: a systematic review and meta‐analysis
  publication-title: Exp Gerontol
– volume: 268
  start-page: 1615
  year: 2021
  end-page: 1622
  article-title: Cognitive assessment tools for mild cognitive impairment screening
  publication-title: J Neurol
– volume: 8
  start-page: 17
  year: 2017
  end-page: 26
  article-title: Nutritional considerations for healthy aging and reduction in age‐related chronic disease
  publication-title: Adv Nutr
– ident: e_1_2_8_12_1
  doi: 10.3233/JAD-210321
– ident: e_1_2_8_50_1
  doi: 10.1002/jcsm.12908
– ident: e_1_2_8_23_1
  doi: 10.1186/s12877-021-02190-1
– ident: e_1_2_8_42_1
  doi: 10.1093/ageing/afy169
– ident: e_1_2_8_39_1
  doi: 10.1159/000513247
– ident: e_1_2_8_13_1
  doi: 10.1016/j.jamda.2017.06.012
– ident: e_1_2_8_9_1
  doi: 10.1016/j.clnu.2018.09.026
– ident: e_1_2_8_6_1
  doi: 10.1017/S0714980809090126
– ident: e_1_2_8_49_1
  doi: 10.1016/j.exger.2019.110798
– ident: e_1_2_8_46_1
  doi: 10.1007/s11920-016-0721-2
– ident: e_1_2_8_47_1
  doi: 10.1016/j.arr.2017.09.003
– ident: e_1_2_8_15_1
  doi: 10.1002/hep.30702
– ident: e_1_2_8_40_1
  doi: 10.3945/an.116.013474
– ident: e_1_2_8_43_1
  doi: 10.1016/S0140-6736(19)31138-9
– ident: e_1_2_8_41_1
  doi: 10.1016/j.freeradbiomed.2018.08.035
– ident: e_1_2_8_48_1
  doi: 10.1007/s11136-017-1651-0
– ident: e_1_2_8_11_1
  doi: 10.1007/s12603-019-1188-8
– ident: e_1_2_8_53_1
  doi: 10.1007/s00415-019-09506-7
– ident: e_1_2_8_18_1
  doi: 10.1016/j.chest.2019.04.115
– ident: e_1_2_8_26_1
  doi: 10.3390/jcm9072133
– ident: e_1_2_8_2_1
  doi: 10.1016/S1474-4422(06)70355-6
– ident: e_1_2_8_33_1
  doi: 10.1016/j.arr.2016.09.008
– ident: e_1_2_8_7_1
  doi: 10.1093/ageing/afy169
– ident: e_1_2_8_14_1
  doi: 10.1186/s12877-020-1468-5
– volume: 47
  start-page: 327
  year: 2018
  ident: e_1_2_8_28_1
  article-title: Sarcopenia is associated with cognitive impairment and depression in elderly Korean women
  publication-title: Iran J Public Health
– ident: e_1_2_8_27_1
  doi: 10.1016/j.clnu.2013.04.002
– ident: e_1_2_8_24_1
  doi: 10.1186/s12877-015-0169-y
– ident: e_1_2_8_16_1
  doi: 10.1016/j.arr.2021.101395
– ident: e_1_2_8_4_1
  doi: 10.1111/jgs.15642
– ident: e_1_2_8_37_1
  doi: 10.1016/j.jamda.2013.05.009
– ident: e_1_2_8_17_1
  doi: 10.1016/j.smrv.2021.101488
– volume-title: World Alzheimer report 2015—the global impact of dementia: an analysis of prevalence, incidence, cost and trends
  year: 2019
  ident: e_1_2_8_3_1
– ident: e_1_2_8_22_1
  doi: 10.1002/jcsm.12787
– ident: e_1_2_8_8_1
  doi: 10.1007/978-3-319-57379-3_19
– ident: e_1_2_8_51_1
  doi: 10.1186/s40200-017-0302-x
– ident: e_1_2_8_45_1
  doi: 10.1016/j.neubiorev.2013.04.005
– ident: e_1_2_8_52_1
  doi: 10.1002/gps.5016
– ident: e_1_2_8_10_1
  doi: 10.1007/s41999-019-00233-w
– ident: e_1_2_8_25_1
  doi: 10.1016/j.jad.2021.02.067
– ident: e_1_2_8_5_1
  doi: 10.1111/acps.12008
– ident: e_1_2_8_29_1
  doi: 10.1111/jgs.17206
– ident: e_1_2_8_44_1
  doi: 10.22540/JFSF-05-017
– ident: e_1_2_8_54_1
  doi: 10.1002/jcsm.12899
– ident: e_1_2_8_20_1
  doi: 10.1007/s40520-021-01883-2
– ident: e_1_2_8_19_1
  doi: 10.1016/j.jaad.2017.05.019
– ident: e_1_2_8_30_1
  doi: 10.1016/j.jalz.2016.07.151
– ident: e_1_2_8_31_1
  doi: 10.1111/jgs.17520
– ident: e_1_2_8_34_1
  doi: 10.1016/j.exger.2019.110801
– ident: e_1_2_8_36_1
  doi: 10.1016/j.biopha.2020.110721
– ident: e_1_2_8_35_1
  doi: 10.1186/s12929-019-0524-y
– ident: e_1_2_8_32_1
  doi: 10.31887/DCNS.2009.11.2/cqiu
– ident: e_1_2_8_38_1
  doi: 10.1016/j.jbspin.2018.08.001
– ident: e_1_2_8_21_1
  doi: 10.2174/1567205013666160211124828
SSID ssj0000461650
Score 2.5243497
SecondaryResourceType review_article
Snippet Sarcopenia is a progressive skeletal muscle disorder involving the loss of muscle mass and function, associated with an increased risk of disability and...
Abstract Sarcopenia is a progressive skeletal muscle disorder involving the loss of muscle mass and function, associated with an increased risk of disability...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 45
SubjectTerms Aged
Alzheimer's disease
Cognitive ability
Cognitive Dysfunction - complications
Cognitive Dysfunction - epidemiology
Cohort analysis
Cross-sectional studies
Dementia
Dementia - complications
elderly
Gait
Humans
Meta-analysis
mild cognitive impairment (MCI)
Older people
Population
Prevalence
Review
Reviews
risk factor
Risk Factors
Sarcopenia
Sarcopenia - complications
Sarcopenia - epidemiology
Systematic review
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k2gICO4gBRaO34eS0VVVVouUKk3y_FDBHWz1e72zk_ob-wvYcZJw66o4MItskeJY8_Y39jjbwh5J5BqUvJcR9W2tYhR1N7HUCspo_YWnIyM-x2zL-r4VJycybONVF8YEzbQAw8dtxcVy5qHLFpYTbK3rZSJNZnvJ59z4BFnX1jzNpypMgcLxVRJz8rxrrQEFDRxk_K9H2E1_8iaclVnYzUqpP23Ic0_AyY3gWxZiY4ekPsjhKQHQ9Mfkjupf0TuzsZD8sdkfUB_8zPT4W4K9X2k87T21z-v_MhDQheZAvyjF0uk_EYLL1IB83UMEXIoMe_OsWwMMqJ4q7Jb4pYi7Xq6AjPB_Fudf0JOjz5_Ozyux-QKdVAAu-rUWBO9AQ81ROuTsS2TSfAok4zQzRxPTcA2VZuDbsHpUGo_ATiKJgvw4HxonpKdftGn54QCZvMitD6nwERq4KWAiqzSAVyjbJSvyPubTnZhZB7HBBjnbuBM5g4HxJUBqcjbSfZi4Nu4VeoTjtUkgRzZpQA0x42a4_6lORXZvRlpNxruynGtmdBaG1ORN1M1mByeo_g-LS5RRkqD-RhlRZ4NijG1pFGSWyZYRfSWymw1dbum774XWm9rLLMCvvuhKNdfft-dHH6dlacX_6MjXpJ7HKDbEIu-S3bWy8v0CqDWun1drOoXQUAp4A
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgLgvIKLcgILiCFNo4fyQmVqlVVablApb1FfkJQN1my2__fGcebdkXVW2SPkjjjcb4Zj78h5BNHqknBQu6kMTl3judaO5tLIZzSNTgZAeMdsx_y7IKfz8U8BdxWKa1ysybGhdr1FmPkB0ypgisFHtu35b8cq0bh7moqofGQPELqMkzpUnM1xViQTFzGIq0MT0wLwEITQyk7-GtXi69FGQ_s3PonRer-u_Dm_2mTt-Fs_B-dPiNPE5CkR6Pmn5MHvtslj2dpq_wFGY7oDUszHU-oUN05uvBrnevERUL7QAEC0uWAtN9o5VHGYs2OMUsOJRbtJbalRCOKJyvbAcOKtO3oCkwFa3C1-iW5OD35dXyWpwILuZUAvXJf1pXTFXip1tXaV7UphOfMCS9cAEXhzgnYpzTBKgOOh5SHHgCSqwIHL07b8hXZ6frOvyEUcJvm1ujgbcF9CTcFZFRLZcE9CpXUGfm8-cSNTezjWATjshl5k1mD6miiOjLycZJdjpwbd0p9R01NEsiTHRv64XeTzK5xsgiK2cANYBEYkhHCF2Vgh16HYJnLyP5Gz00y3lVzM9Uy8mHqBrPDvRTd-f4KZYSosCajyMjrcVpMb1JKweqCFxlRWxNm61W3e7r2T6T2rqu6qDk890ucWvcMvzk__jmLV2_vH8MeecIAmI2Z5vtkZz1c-XcApNbmfbSWa4wlHjo
  priority: 102
  providerName: ProQuest
– databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9RAFD7UCuKLeDe1yoi-KMQ2k7kk4EstllJYEbTQtzDXGulmy-72vT_B3-gv8ZxJNutiEXwLycn1zJf5zsyc7wC8ESQ1KXnMvbI2F96L3BjvciWl16bGICPSeMfkszo-FSdn8mwLPqxyYXp9iHHAjZCR_tcEcGMXe2vR0B9uMX1flNjf34LblFtLyvlcfBlHWEhKXKUSrZzypSUyoVGflO-tT9_okZJw_01s8-9Fk3-S2dQbHd2HewONZAe93x_AVugewp3JMFH-CJYHbK3RzPr8FGY6z6ZhaX5d_zSDFgmbRYYUkF3OSfabUJ6sHNXs6FfJkcW0vaB9w0IjRpmV7ZyGFVnbsQVChWpwteYxnB59-nZ4nA8FFnKnkHrloawrbyqMUp2vTahqW8gguJdB-oiOopkTxKey0WmLgYdS-wEJkq-iwCjOuPIJbHezLjwDhrzNCGdNDK4QocSLIjOqlXYYHsVKmQzerj5y4wb1cSqCcdH0usm8IYc0ySEZvB5tL3vNjRutPpKvRgvSyU47ZvPzZoBd41URNXdRWOQi-EpWylCUke8HE6PjPoPdlaebAbyLhmtdCK11VWXwajyMsKO5FNOF2RXZSFlRTUaZwdO-YYxPUirJ60IUGeiNJrPxqJtHuvZ7kvauq7qoBd73XWpc_3j95uTw6yRt7fyP8XO4y5Gm9evOd2F7Ob8KL5BWLe3LhJ7f0jEhAw
  priority: 102
  providerName: Wiley-Blackwell
Title A systematic review and meta‐analysis of the prevalence and correlation of mild cognitive impairment in sarcopenia
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcsm.13143
https://www.ncbi.nlm.nih.gov/pubmed/36529141
https://www.proquest.com/docview/2771477788
https://www.proquest.com/docview/2755800585
https://pubmed.ncbi.nlm.nih.gov/PMC9891948
https://doaj.org/article/d61f72cf4b024fa9b55e13f20eaffc2d
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFD70AqUv4t1oXUb0RSG1mcwleRBpS0spbCnqwr6FyVxqZDdbs1vQN3-Cv9Ff4plJsnZx8cGXEDInl5lzTuY7c_kOwCvmqSY5dbERZRkzY1islNGx4NxIlWOQ4fx4x_BCnI3Y-ZiPN6DP39k14HxtaOfzSY2ayf63r9_fo8O_6whE337R8-l-kmLPvwnb2CNJ76DDDuaHPzITiQjJWqnfOc0REy2ZSm_fvgs7qeA0T1iy0k0FNv91EPTvlZS3EW7ook7vwp0OW5LD1hjuwYat78POsJs9fwCLQ_KHuJm0m1aIqg2Z2oX69eOn6ghKyMwRxIXkuvFc4N71g5T2iTzapXNeYlpN_LVu9RHx2y2rxo81kqomc_Qf35CVegij05NPx2dxl3Uh1gLxWGzTPDMqw9BVm1zZLC8Tbhk13HLjUHt-OgWdVpROyxKjESEOLKImkzmGoZ3S6SPYqme1fQIEwZxiulTO6oTZFB-KcCkXUmPM5DKhInjdN3KhO0pynxljUrRkyrTwuimCbiJ4uZS9bok41kodeV0tJTx5drgwa66KzhcLIxInqXasRICCVSo5t0nq6IFVzmlqItjrNV30BllQKRMmpcyyCF4si9EX_QSLqu3sxstwnvlEjTyCx61hLL-kN6wI5IrJrHzqakldfQ5833mWJznD974JxvWP6hfnxx-H4ezpf7_mGexSBHLtyvQ92Fo0N_Y5Aq9FOYBNyi7xKMdyANtHJxeXHwZhEGMQ_O03aQ8zsQ
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRcEG8CBYyAA0ihjWM7yQGhtrTaPnaFoJV6Sx0_2kXd7LK7FeJP8RuZSbJpV1S99RYlo8T2jJ1v7JlvAN4JopqU3IdWFUUorBWh1taESkqb6AydDE_7Hb2-6h6K3SN5tAR_57kwFFY5XxOrhdqODO2Rr_IkiUSSoMf2ZfwrpKpRdLo6L6FRm8We-_MbXbbp552vqN_3nG9vHWx2w6aqQGgU4o3QxVlqdYqumbGZdmlWRNIJbqWT1mPr6LgAjVIV3iQFom2l1hyiApt6ga6LNjG-9xYsixhdmQ4sb2z1v31vd3WIvlxVZWE55WhLRF8tJypf_Wmmw09RXKUIXfoLVsUCrkK4_wdqXgbQ1R9w-z7ca6ArW69t7QEsufIh3O41h_OPYLLOLnihWZ0Tw3Rp2dDNdKgb9hM28gxBJxtPiGic1pVKxlCVkDoujySGgzO614Q2McrlHExoI5MNSjZFLVDVr4F-DIc3MvhPoFOOSvcMGCJFLUyhvTORcDG-FLFYphKDDplPlQ7gw3yIc9PwnVPZjbO8ZmrmOakjr9QRwNtWdlyzfFwptUGaaiWImbu6MZqc5M1Ez62KfMKNFwWiH-xSIaWLYs_XnPbecBvAylzPebNcTPML4w7gTfsYJzqd3ujSjc5JRsqUqkDKAJ7WZtG2JFaSZ5GIAkgWDGahqYtPysFpRSaepVmUCfzux8q0rul-vrv5o1ddPb--D6_hTvegt5_v7_T3XsBdjrCwjnNfgc5scu5eIoybFa-aucPg-Kan6z9SQluF
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIlVcEG8MBRYBB5BM6vU-7ANCpSXqg1RIUCk3s94HBDVOcFIh_hq_jpn1o42oeustskfOrmdm_c3uzDeEvORINSmYj60sy5hby2OtrYmlEFbpHIIMj_sdoyO5d8wPxmK8Rv52tTCYVtmtiWGhtjODe-QDplTClYKIbeDbtIjPu8P3818xdpDCk9aunUZjIofuz28I3xbv9ndB168YG378urMXtx0GYiMBe8QuzTOrMwjTjM21y_IyEY4zK5ywHkaKRwdgoLL0RpWAvKXccoAQbOY5hDHapPDca-S6SkWCPqbGqt_fQSJzGRrEMqzWFoDDenZUNvhpFtO3SRqKhc59D0PbgIuw7v8pm-ehdPgWDm-Rmy2IpduN1d0ma666QzZG7TH9XVJv0zOGaNpUx1BdWTp1Sx3rlgeFzjwF-EnnNVKO4woTZAz2C2ky9FBiOjnBa22SE8WqzkmNW5p0UtEF6AD7f030PXJ8Ja_-PlmvZpV7SChgRs1Nqb0zCXcpPBRQWS6VgdDMZ1JH5HX3igvTMp9jA46TouFsZgWqowjqiMiLXnbe8H1cKPUBNdVLIEd3uDCrvxetyxdWJl4x43kJOAimVArhktSzLae9N8xGZLPTc9EuHIvizMwj8ry_DS6P5zi6crNTlBEiw36QIiIPGrPoR5JKwfKEJxFRKwazMtTVO9XkR6AVz7M8yTn875tgWpdMvzjY-TIKvx5dPodnZAOctPi0f3T4mNxggA-bhPdNsr6sT90TwHPL8mlwHEq-XbWn_gOTMV5V
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+systematic+review+and+meta%E2%80%90analysis+of+the+prevalence+and+correlation+of+mild+cognitive+impairment+in+sarcopenia&rft.jtitle=Journal+of+cachexia%2C+sarcopenia+and+muscle&rft.au=Yang%2C+Ying&rft.au=Xiao%2C+Mengmeng&rft.au=Leng%2C+Lin&rft.au=Jiang%2C+Shixie&rft.date=2023-02-01&rft.pub=John+Wiley+and+Sons+Inc&rft.issn=2190-5991&rft.eissn=2190-6009&rft.volume=14&rft.issue=1&rft.spage=45&rft.epage=56&rft_id=info:doi/10.1002%2Fjcsm.13143&rft_id=info%3Apmid%2F36529141&rft.externalDocID=PMC9891948
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2190-5991&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2190-5991&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2190-5991&client=summon